Browse articles from EyeWorld.org related to the retina. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ Results from Phase 3 trials for non-infectious uveitis treatment ➤ FDA allows new gene therapy for Leber congenital amaurosis to begin clinical testing ➤ FDA approves OTC drop for redness ➤ Company news ➤ ASCRS news and events ➤ EyeWorld article of the week
➤ FDA approves ‘world’s first’ spiral IOL platform ➤ Company to submit formal appeal after FDA’s denial of dry eye disease NDA ➤ FDA to hold Advisory Committee meeting for low-dose atropine treatment for myopia ➤ Positive results in Phase 3 trial for AMD treatment ➤ Phase 3 trial investigating DME treatment begins ➤ ASCRS news and events ➤ EyeWorld article of the week
There are several all-in-one phacovitrectomy machines on the market that seek to streamline workflows, reduce equipment footprint, and improve efficiency. The decision to invest in a combined system depends on case mix, staffing patterns, and how often vitreous management is needed in the cataract OR. Three physicians weighed in on the topic.
➤ AMA classifies myopia as a disease ➤ Report marks shift in refractive surgery trends ➤ Patient dosing begins in Phase 2 trial for oral DME therapy ➤ ASCRS news and events ➤ EyeWorld article of the week
➤ Launch of biosimilar for retinal disease ➤ New partnership to advance perimetry program ➤ Approval of thyroid eye disease treatment ➤ Collaboration to develop adjustable PCIOLs ➤ Progress in treatment for neuropathic corneal pain ➤ Priority review for thyroid eye disease treatment ➤ RMAT designation granted to investigational magnetic human corneal endothelial cell therapy ➤ Complimentary access to video journal ➤ ASCRS news and events ➤ EyeWorld article of the week
➤ First patient dosed in Phase 3 trial for treatment of X-linked retinoschisis ➤ New treatment option for glaucoma ➤ BLA resubmission received by FDA for wet AMD treatment ➤ Company news ➤ Grant opportunity ➤ ASCRS news and events ➤ EyeWorld article of the week
➤ Phase 3 clinical program complete for epithelium-on crosslinking treatment ➤ NDA submitted for oral Stargardt disease therapy ➤ Preclinical data shared for investigational TED therapy ➤ Three new clinical programs to begin for inherited retinal diseases ➤ ASCRS news and events ➤ EyeWorld article of the week
➤ First patient dosed in Phase 3 trial evaluating cenegermin for PCED ➤ First patient dosed in Phase 3 study for Stargardt treatment ➤ First patient randomized into registrational trial for first-in-class dry eye therapy ➤ FDA clears new software for retinal imaging machine ➤ Company news ➤ ASCRS news and events ➤ EyeWorld article of the week
➤ FDA Orphan Drug and Fast Track Designations granted to investigational NK therapy ➤ DME drop study does not meet Phase 3 endpoint ➤ Phase 1b trial begins for first-in-class DME treatment ➤ ASCRS news and events ➤ EyeWorld article of the week
➤ FDA 510(k) clearance granted to non-invasive glaucoma treatment ➤ Study: GA treatment increases probability of driving capabilities among patients ➤ Third implantation of wireless visual prosthesis in the brain ➤ First-in-human results for geographic atrophy therapy ➤ SPA agreement with the FDA for optic neuritis trial ➤ Company news ➤ ASCRS news and events ➤ EyeWorld article of the week
Get the latest ophthalmology news delivered to your inbox every Friday.